Adiponectin multimer distribution in patients with familial combined hyperlipidemia

TB Koenen, LJH van Tits, S Holewijn… - Biochemical and …, 2008 - Elsevier
TB Koenen, LJH van Tits, S Holewijn, HLM Lemmers, M den Heijer, AFH Stalenhoef…
Biochemical and biophysical research communications, 2008Elsevier
Adiponectin is secreted from adipocytes in different multimers, of which the high molecular
weight (HMW) form is supposed to mediate favorable metabolic and anti-atherogenic effects.
We determined adiponectin multimers in 29 female and 22 male patients with familial
combined hyperlipidemia (FCH) and 51 age-, gender-, and BMI-matched controls in relation
to cardiovascular disease (CVD). We observed a clear sexual dimorphism of total
adiponectin and its multimers. Female, but not male, FCH patients had significant lower total …
Adiponectin is secreted from adipocytes in different multimers, of which the high molecular weight (HMW) form is supposed to mediate favorable metabolic and anti-atherogenic effects. We determined adiponectin multimers in 29 female and 22 male patients with familial combined hyperlipidemia (FCH) and 51 age-, gender-, and BMI-matched controls in relation to cardiovascular disease (CVD). We observed a clear sexual dimorphism of total adiponectin and its multimers. Female, but not male, FCH patients had significant lower total adiponectin and both HMW and low molecular weight (LMW) adiponectin than controls. The adiponectin sensitivity index (ASI), reflected by HMW/total adiponectin, and the LMW/HMW adiponectin ratio did not differ significantly between FCH females and control females. However, FCH females with CVD exhibited significantly lower ASI (34.2±10.1% vs 46.0±7.1%) and higher LMW/HMW ratio (1.5±0.8 vs 0.7±0.3) compared to FCH females without CVD, reflecting a more atherogenic adiponectin multimer distribution.
Elsevier